APELLIS PHARMACEUTICALS INC

Ticker: APLS CUSIP: 03753U106 Class: Common Stock

FRONTIER CAPITAL MANAGEMENT CO LLC's Holding History (CIK: 0000351173)

Note: Option positions (PUT/CALL) are excluded.

Q2 2024

Shares 77,561 Value ($000) $2,975 Avg Close $45.29 Range $37.00 - $59.91

Q1 2024

Shares 78,048 Value ($000) $4,588 Avg Close $63.75 Range $53.19 - $73.80

Q3 2023

Shares 34,600 Value ($000) $1,316 Avg Close $43.93 Range $19.83 - $91.35

Q3 2022

Shares 6,193 Value ($000) $423 Avg Close $59.17 Range $44.07 - $70.00

Q2 2022

Shares 6,060 Value ($000) $274 Avg Close $45.59 Range $33.32 - $60.20

Q1 2022

Shares 15,549 Value ($000) $790 Avg Close $44.15 Range $33.50 - $54.51

Q4 2021

Shares 123,490 Value ($000) $5,839 Avg Close $39.37 Range $30.17 - $50.31

Q3 2021

Shares 275,910 Value ($000) $9,094 Avg Close $56.19 Range $27.50 - $73.00

Q2 2021

Shares 177,525 Value ($000) $11,220 Avg Close $51.60 Range $40.53 - $66.07

Period	Shares	Value ($000)	Average Close	Price Range
Q2 2024	77,561	$2,975	$45.29	$37.00 - $59.91
Q1 2024	78,048	$4,588	$63.75	$53.19 - $73.80
Q3 2023	34,600	$1,316	$43.93	$19.83 - $91.35
Q3 2022	6,193	$423	$59.17	$44.07 - $70.00
Q2 2022	6,060	$274	$45.59	$33.32 - $60.20
Q1 2022	15,549	$790	$44.15	$33.50 - $54.51
Q4 2021	123,490	$5,839	$39.37	$30.17 - $50.31
Q3 2021	275,910	$9,094	$56.19	$27.50 - $73.00
Q2 2021	177,525	$11,220	$51.60	$40.53 - $66.07